Conference Abstracts

181 results

Understanding Asthma-Specific Fear, Worry and Phobia in relation to Clinical Outcomes; A Systematic Review (ID 794)

Garang RA, Steed L

Queen Mary University of London

“Respiratory just isn’t sexy”: clinicians’ experiences of spirometry for COPD diagnosis in UK primary care (ID 795)

Roleston C, Glogowska M, Wolstenholme J, Koleva-Kolarova R, Hayward G, Campbell L, Turner P, Ashdown, HF

University of Oxford

Spirometry provision for COPD diagnosis across the UK: findings from a national survey of healthcare professionals (ID 796)

Roleston C, Glogowska M, Wolstenholme J, Koleva-Kolarova R, Hayward G, Turner P, Ashdown HF.

University of Oxford

Using a modified Esther model to develop a blueprint for Neighbourhood Health in chronic obstructive pulmonary disease (COPD) (ID 797)

Katherine Hickman, on behalf of PCRS committees and neighbourhood health project group

Primary Care Respiratory Society (PCRS)

The fit between asthma self-management implementation strategies and practice context– a case study within the IMP2ART cluster randomised controlled trial (ID 800)

Sheringham J, Delaney B, MacLeod C, McClatchey K, Barat A, Steed L, Marsh V, Hammersley V, Taylor SJC, Pinnock H

University College London (UCL)

MDI Optimisation Service: A Neighbourhood Health Initiative Removing the Adherence Blind Spot through GP-Pharmacy Cooperation (ID 801)

Negandhi D, Antalffy T

Smart Respiratory

Modifiable Risk Factors in patients referred to Severe Asthma Services: Implications for Primary Care Education and Referral

Could medicine optimisation and improved patient adherence in primary care reduce the number of patients referred to the secondary care difficult asthma service? (ID 802)

Greenwood S, O’Driscoll M, Beswick S, Haughney J, McKnight E

National Services for Health Improvement

Effectiveness of a facilitated implementation strategy to improve routine delivery of supported asthma self-management in UK primary care: a cluster randomised implementation trial (IMP2ART) (ID 803)

Pinnock H, Hammersley V, Appiagyei F, Barat A, Delaney B, Fitzsimmons D, Hamborg T, Holmes S, Jackson T, Jones M, Julious S, MacLeod C, McClatchey K, Marsh V, Morgan N, Price D, Sheringham J, Steed L, Stuart B, Taylor SJC for the IMP2ART study team

The University of Edinburgh

Are Patients with Cluster Headache Prescribed Short-Burst Oxygen Adequately Assessed and Monitored? (ID 804)

Imogah SE, Wilson V, Thomas R

Whaddon Medical Centre

Improving inpatient screening for Undiagnosed Obstructive Sleep Apnoea in High-Risk Respiratory Admissions. (ID 805)

Ghafar R, Pornsakulpaisal R, Khan A,Pradhan A.

University hospitals Derby and Burton NHS trust

Operational performance of an artificial intelligence-enabled diagnostic service for chronic obstructive pulmonary disease in primary care (ID 806)

Greason C, Cook L, Harris D, Jordan M, Varghese A, Dempsey J

GP Primary Choice

Is ambulatory oxygen necessary and utilized on post hospital discharge (ID 807)

Wilson VL, Thomas R

Whaddon Medical Centre

Impact of a structured cardiopulmonary risk–focused COPD review in primary care (ID 808)

Young C, McBride M, Courtenay A

Mid-Ulster GP Federation

Feasibility and acceptability of N-Tidal Diagnose: community lung health event feedback (ID 809)

Geeves ME, Denton S, Burke H, Lambert G, Saynor ZL, Wilkinson TM

University Hospital Southampton NHS Foundation Trust

Embedding meaningful patient and public involvement from application to dissemination: lessons from IMP2ART (ID 810)

Jackson T, Ehrlich E, Morgan N, Hammersley V, Healy E, Taylor SJC, Pinnock H

University of Edinburgh

Online Consultations for Asthma Care: Evidence and Practice (ID 811)

Uzzaman N, Hammersley V, Sheringham J, McClatchey K, Habib GMM, Singh D, Pinnock H

The University of Edinburgh

How engagement in pulmonary rehabilitation is affected by the addition of a social prescribing link worker to the multi-disciplinary team. (ID 813)

Parker N, Pritchard L, Moth L

Guys and St Thomas Trust

Reducing health inequalities in pulmonary rehabilitation with social prescribing. (ID 814)

Parker N, Pritchard L, Moth L

Guys and St Thomas Trust

Moderate and Severe COPD Exacerbations Lead to Sustained Impairment in Health-related Quality of Life (ID 815)

Yang S, Weir J, Dalén J, Hughes O, Martin A, Baker T, Shah D, Gould S

GSK

Disease Stability is Achievable in a Wide Spectrum of Patients with Chronic Obstructive Pulmonary Disease Receiving Mepolizumab: Pooled Results From Phase III Randomized Controlled Trials (ID 816)

Singh D, Vogelmeier CF, Martinez FJ, Roche N, Watz H, Bolaji J, Biswas A, Stacey R, Kolterer, Han MK

GSK

Does ethnicity influence the investigative pathway after presentation with breathlessness? – an epidemiological study using CPRD records (ID 817)

Harini Sathanapally, Urvee Karsanji, Jennifer Creese, Gillian Doe, Kamlesh Khunti, Michael Steiner, Claire Lawson, Anvesha Singh, Rachael A Evans

University of Leicester

Transforming COPD Care across the Humber: proactive identification and risk management across the care pathway (Humber COPD ProCare) (ID 818)

Crooks MG, Watkins K, Brindle K, Blackwell K, Denham I, Drydale O, Bowness D, Deayton N, Faruqi S.

NHS Humber Health Partnership

Mepolizumab Reduces Systemic Corticosteroid Utilization in Chronic Obstructive Pulmonary Disease With Type 2 Inflammation: Pooled Results From Phase III Randomised Trials (ID 819)

Hanania NA, Kraft M, Weir J, Burrows E, Biswas A, Gould S, Min J

GSK

Raised Blood Eosinophil Counts are Associated with High Airway Type 2 Inflammation in Chronic Obstructive Pulmonary Disease (ID 820)

Chari S, Weir J, Betts J, Min J, Kolterer S, Chen R

GSK

Evidence-based implementation for large scale change in asthma management - a collation of case studies submitted to NICE on implementation of guideline NG245 - Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) (ID 822)

McCormack J, Taylor E

National Institute for Health and Care Excellence